Dozens of MBS treatments "low value"

Only about 3% of the 6000 MBS items on the schedule have been formally assessed against contemporary evidence for safety, efficacy and cost-effectiveness.

Writing in the November 19 issue of Medical Journal of Australia, researchers searched multiple sources, including the Cochrane library, to track the evidence underpinning existing MBS services.

They produced a list of 156 “low value” items.